Company

Dr. Jan Petracek is the CEO of iVigee and a globally recognized expert in pharmacovigilance, with over 25 years of experience in regulatory leadership, entrepreneurship, and public health. He has built and led multiple successful organizations—including PharmInvent and PrimeVigilance—and served in senior roles at the EMA, Biogen, and Vertex, earning accolades like the DIA Excellence in Service Award. As a founder of the Institute of Pharmacovigilance and a champion of professional standards, Jan is advancing global certification programs and delivering pragmatic, innovation-driven safety solutions to biopharma clients.

Dr. Marcela Fialova is the COO and Co-founder of iVigee, bringing over 20 years of leadership experience in pharmacovigilance, regulatory affairs, and clinical operations. She has led large international teams and held EU QPPV roles across top service providers and pharma companies, including PrimeVigilance, PharmInvent, and Zentiva. Known for her strategic mindset, operational rigor, and commitment to patient safety, Marcela has built iVigee’s pharmacovigilance team across multiple continents, serving dozens of clients both in clinical and post-marketing phases, and drives global service excellence and quality management.

Dr. Henry Seto is the Chief Medical Officer at iVigee, bringing over two decades of leadership in global patient safety from top-tier biopharma companies including Vertex, BMS, and Pfizer. A board-certified cardiologist with experience in both private practice and translational medicine, he has led safety strategy, risk management, and compliance across the full drug development lifecycle. With deep expertise in regulatory science and medical governance, Henry now drives iVigee’s clinical and safety vision to support complex therapeutic areas and regulatory interactions.

Kane Smith is Head of Business Development at iVigee, where he leads commercial strategy and revenue operations for our products and services in pharmacovigilance. Starting his career as an engineer with Boston Scientific and Bayer, he has spent the last decade driving sales and marketing execution across software, medical device, and biopharma industries. Having held similar roles at Definitive Healthcare and Smith & Nephew, Kane focuses on building practical, customer-focused growth strategies in the healthcare and life sciences sectors, and delighting our clients at every chance.

Alex Mole is the Chief Financial Officer at iVigee, bringing over two decades of financial leadership across medical devices, semiconductors, and software. He has led finance, M&A, ERP implementations, and international operations for companies including Ergomed, Chiltern, and Samsung Semiconductors, with a track record of building scalable finance teams across EMEA and Asia-Pacific. Known for driving operational transformation and strategic planning, Alex now supports iVigee’s global growth with financial rigor and commercial insight.